Neutrophils are found to be infiltrated in tumour tissues of patients with colitis-associated cancer (CAC) and colorectal cancer (CRC), and CD177 is mainly expressed in neutrophils. In our study, expression of CD177 in tumour tissues from patients with CAC or CRC was analysed byquantitative real-time polymerase chain reaction, flow cytometry and immunohistochemistry. We recruited 378 patients with CRC, determined CD177 expression in tumours and examined its correlation with clinicopathological features. Moreover, CAC model was induced in wild-type and CD177 -/-mice by azoxymethane/dextran sodium sulphate. CD177 + neutrophils were significantly increased in colon tumour tissues from patients with CRC or CAC compared with controls. Expression of CD177 mRNA and percentages of CD177 + neutrophils were also markedly increased in tumour tissues from CRC patients compared with controls. Patients with high density of CD177 + neutrophils had better overall survival and disease-free survival compared with controls. Multivariate analyses revealed that the density of CD177 + neutrophils was an independent factor in predicting overall survival and disease-free survival. Consistently, CD177 depletion aggravated azoxymethane/dextran sodium sulphate-induced CAC in mice. Expression of Ki67 and proliferating cell nuclear antigen was increased in tumour tissues from CD177 -/-mice compared with wild-type counterparts. Moreover, CD177
Introduction
More than one million new cases are diagnosed with colorectal cancer (CRC) worldwide every year (1) . CRC, the third most common malignancy in the incidence and mortality, is considered as a major cause of cancer-related death (1) . It has been reported that the etiology and pathology of CRC are associated with genetic mutations, familial heredity, environmental triggers, specific intestinal commensal microbiota and pathogens, and chronic intestinal mucosal inflammation (2, 3) . Accumulation of mutations in oncogenes or tumour suppressor genes leads to aberrant activation of several signaling pathways (e.g. β-catenin, Wnt and mTOR), which are capable of mediating the transition of single pre-neoplastic cells to aberrant crypt foci, adenoma and then colorectal carcinoma (2, 4, 5) . Another subtype of CRC is colitisassociated cancer (CAC), which is associated with uncontrollable inflammation in patients with inflammatory bowel disease (6) . Chronic inflammation, characterised by production of pro-inflammatory cytokines and chemokines, could induce genetic mutations (e.g. adenomatous polyposis coli, p53 and K-ras), promote tumour growth and suppress immune-mediated tumour elimination (7) (8) (9) . Moreover, persistent inflammation also activates proliferation and apoptosis of premalignant cells, which further facilitate tumour promotion, progression and metastasis (2) .
The role of immune systems in tumourigenesis appears to be much more complicated, which mainly consist of a variety of immune cells, such as dendritic cells, natural killer cells, neutrophils, macrophages and cytotoxic CD8 + T cells (10, 11) . Immune cells function differently in tumour microenvironment. They can counteract tumour growth by stimulating T-cell-mediated antitumour immunity, or promote tumour progression through stimulating angiogenesis or secreting growth factors (e.g. vascular endothelial growth factor and prostaglandin E2) (11) (12) (13) . Among them, neutrophils (polymorphonuclear leukocytes) are an indispensable component and show high functional plasticity including both antitumour and pro-tumour activities. Transforming growth factor-β (TGF-β) is reported to be a regulator of neutrophil function, which promotes the polarization of neutrophils into a pro-tumoural N2 phenotype, characterised by high pro-angiogenic, pro-metastatic and immunosuppressive activities. However, neutrophils can also shift to an N1 phenotype following TGF-β inhibition, characterised by high cytotoxic activity, high capacity to generate hydrogen peroxide and immunostimulating activity (14) (15) (16) . CD177, a 58-64-kDa glycosylphosphatidylinositol-anchored glycoprotein, is mainly expressed in neutrophils. Under physiological conditions, CD177 expression in neutrophils ranges from 45% to 60%, and is upregulated during acute inflammation (17) . It has been reported that CD177 mRNA expression is increased in gastric cancer induced by Helicobacter pylori-infected and high-salt diet (18) . However, the roles of CD177 + neutrophils in the pathogenesis of CRC and CAC are still obscure.
In this study, we aimed to evaluate the potential roles of CD177 + neutrophils in the pathogenesis of patients with CAC and CRC. Our data demonstrated that the expression of CD177 + neutrophils was highly increased in tumour tissues of patients with CAC and CRC, and that patients with high density of CD177 + neutrophils had better overall survival (OS) and diseasefree survival (DFS). Importantly, we found that the density of CD177 + neutrophils was an independent factor in predicting good prognosis of CRC, and that depletion of CD177 aggravated the development of CAC in mice. Therefore, CD177 + neutrophils may serve as a novel therapeutic target in the treatment and predict the prognosis of CAC and CRC.
Materials and methods

Reagents
Anti-human CD177 and CD66B mAbs were purchased from BD (San Diego, CA, USA). Azoxymethane (AOM) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Live/Dead Fixable Dead Cell stain kits were purchased from Life Technologies (Carlsbad, CA, USA). TRIzol Reagent was purchased from Life Invitrogen (Carlsbad, CA, USA). 5×All-in-one RT Mastermix was purchased from abm (Peterborough, Cambs, Canada). DAB Detection Kit was purchased from BOSTER (Wuhan, China).
Patients and specimens
Freshly isolated colorectal tumour tissues (T, n = 16) and paired distant normal colon tissues adjacent to tumour area (DN, n = 16) were obtained from patients with CRC who received curative surgery in the Department of General Surgery, the Shanghai Tenth People's Hospital of Tongji University (Shanghai, China) from October 2013 to May 2016. Normal colonic mucosal biopsies were collected from healthy controls (HC, n = 16) who underwent endoscopy at the Department of Gastroenterology of our hospital from October 2013 to May 2016. These tissue samples were used for quantitative real-time polymerase chain reaction (qRT-PCR) and flow cytometric analysis. Moreover, a total of 378 qualified formalin-fixed paraffin-embedded surgical specimens derived from CRC patients who underwent radical resection at the Department of General Surgery of Ruijin Hospital, Shanghai Jiaotong University (Shanghai, China) from April 2008 to December 2010 were collected and then subjected to tissue microarray construction. None of patients had received radiotherapy or chemotherapy before surgery, and patients with other malignant diseases or died from other causes were excluded. Tumour staging was carried out according to the 7th edition of American Joint Committee on Cancer (AJCC) staging system (19) . All patients were followed-up until death or until the final follow-up (March 2015 
Quantitative real-time polymerase chain reaction
Total RNA was extracted from colorectal tumours, paired distant normal colon tissues and healthy biopsies using TRIzol Reagent. The complementary DNA was synthesised with 5×All-in-one RT Mastermix according to the manufacturer's instructions. The synthesised cDNA was stored at −20°C. qRT-PCR was performed using SYBR green methodology according to the following conditions: 95°C for 1 min, followed by 40 cycles at 95°C for 15 s and 60°C for 30 s with 40 cycles. Gene expression was normalised to glyceraldehyde 3-phosphate dehydrogenase. The primers used in this study were shown in Supplementary Table 2, available at Carcinogenesis Online. The relative levels of target gene expression were calculated using the 2 −△△Ct method (20) .
Isolation of leukocytes from colorectal tumour and colon biopsies
As described previously (21) , obtained colorectal tumours, paired distant normal colon tissues and healthy biopsies were sliced into 0.5-1.0 cm pieces, and washed with ice-cold phosphate-buffered saline (PBS) to remove blood, fecal contents and debris. After removing epithelia by gently shaking in PBS supplemented with 1 mM ethylenediaminetetraacetic acid and 10% fetal bovine serum at 37°C for 20 × 2 min, the tissues were digested in 20-30 mL of 5% fetal bovine serum-RPMI-collagenase A (1 mg/ mL) and 10 μg/mL DNase at 37°C for 30 min. Cells were collected and further purified via density gradient centrifugation with 40% and 70% percoll-RPMI solution. The interface containing leukocytes was collected and supplemented with 10% fetal bovine serum-RPMI medium for further analysis.
Immunohistochemistry
Tissue microarray was sectioned at 4-μm thick, and heated at 80°C for 30 min. The slides were then deparaffinised and rehydrated in xylene and ethanol. To facilitate antigen retrieval, the sections were heated in ethylenediaminetetraacetic acid-Tris buffer (pH 9.0) for 30 min at 90°C. After achieving antigen retrieval, the slides were treated with 3% H 2 O 2 at 37°C for 5 min and incubated in a moist chamber at 37°C with primary mouse monoclonal antibody against human CD177 (1:200; Abcam) for 1 h. For negative controls, the sections were incubated with PBS instead of specific primary antibody. Color staining was achieved with DAB Detection Kit (BOSTER; Wuhan, China) using a peroxidase activity and diaminobenzidine as a chromogen. At the end, slides were counterstained with haematoxylin and mounted. The sections were finally observed under an optical microscopy (Leica Microsystems; Wetzlar, Germany) by two independent researchers (K.P., G.Z.) blinded to clinical information. Each tissue section was reviewed and scored by counting the number of CD177 + neutrophils by counting stromal cells and epithelial cells on six randomly selected representative fields under ×400 magnification, and took the mean of six counts. The density of CD177 + neutrophils in CRC was determined by the mean number of positively stained cells per high-power microscopic field (HPF, ×400). According to the median density of CD177 + neutrophils, the patients were classified into high-and low-density groups (22) .
Flow cytometry
Cells (1 × 10 6 ) were incubated with fluorochrome-conjugated mAbs or isotype matched-control mAbs for 30 min at 4°C. Flow-cytometric analysis was performed on a BD FACSCanto II (BD Biosciences; San Diego, CA, USA), and analysed using Flowjo_V10 software (FLOWJO, LLC; Ashland, OR, USA). In human, neutrophils were gated as CD66B + cells, and CD177 + neutrophils were gated as CD66B + CD177 + cells. In mouse, neutrophils were gated as CD11b + Ly6G + cells for further analysis.
Mice
C57BL/6 J CD177 -/-mice were purchased from the KOMP in University of California (Davis, CA, USA) and bred at the animal facility of the Shanghai Tenth People's Hospital (23) . CD177 -/-and C57BL/6 J wild-type (WT) mice were raised in microisolator cages with filtered air under specific pathogen-free conditions, and free access to sterile water and autoclaved food. Mice used in the experiment were at 8−10 weeks of age and 20-25 g of weight. Animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of Tongji University.
AOM/DSS-induced CAC model
As previously described, CAC model in mice was induced by AOM/dextran sodium sulphate (DSS, molecular mass, 36 000-50 000, MP Biomedicals, LLC; Solon, OH, USA) (24) . WT (n = 20) and CD177 -/-(n = 30) mice were first injected intraperitoneally with 10 mg/kg of AOM on day 0. At the beginning of day 7, 1.5% DSS was administered to mice in drinking water for 7 continuous days, followed by 14 days of regular water. This cycle was repeated twice until day 81 when all mice were sacrificed. Another two groups of WT and CD177 -/-mice were given regular water as controls.
Neutrophil migration assay in vitro
Neutrophils (5 × 10 5 ) from the bone marrow of WT and CD177 -/-mice were suspended in 100 μL PBS containing 0.1% BSA, and placed on the upper wells of a 5-μm-Transwell plate. fMLP was loaded in the bottom wells. After 30 min of incubation, migrated neutrophils were then counted under microscopy.
Statistical analysis
All data were expressed as mean ± SEM and analysed using SPSS V.20.0 (SPSS; Chicago, IL, USA). Statistical comparisons were performed using an unpaired two-tailed Student's t-test. Associations of the density of CD177 + neutrophils with clinicopathological characteristics were analysed using chi-squared test or student's t-test. OS was calculated from the date of surgery to the date of death or the last follow-up. DFS was estimated from the date of surgery to the date of disease recurrence or metastasis or the date of last follow-up. OS and DFS were calculated using the Kaplan-Meier method and compared using the log-rank test. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using univariate and multivariate Cox regression analysis. *P < 0.05, **P < 0.01, and ***P < 0.001 were considered as statistical significance.
Results
CD177 is highly expressed in tumour tissues of patients with CRC and CAC
It has been reported that CD177 expression is highly increased in acute inflammation and gastric cancer (17,18); we explored whether CD177 expression was increased in tumour tissues of patients with CRC. First, we examined the expression of CD177 + neutrophils in colon tumour tissues, paired distant normal colon tissues adjacent to tumour areas and normal colon mucosa from HC by immunohistochemistry. We observed that CD177 + neutrophils were markedly increased in colorectal tumours compared with those in paired distant normal colon tissues and HC ( Figure 1A and B). Since evidences have demonstrated that patients with ulcerative colitis (UC) account for a risk in developing CAC, we also examined the expression of CD177 + neutrophils in patients with UC and UC-associated cancer by immunohistochemistry. We found that the expression of CD177 + neutrophils was also significantly increased in inflamed mucosa of patients with UC and UC-associated cancer compared with HC ( Figure 1C and D) . Moreover, CD177 mRNA expression was further confirmed to be markedly increased in colorectal tumour tissues compared with controls by qRT-PCR. CD177 mRNA expression was about two-fold changes in colorectal tumour tissues compared with that in HC and distant normal colon tissues (Figure 2A ). However, no significant difference in CD177 mRNA expression was found between distant normal colon tissues and HC (Figure 2A ). Moreover, leukocytes were isolated from freshly isolated colorectal tumours, paired distant normal colon tissues and HC, the percentages of CD66 + neutrophils and CD177 + CD66 + neutrophils were determined by flow cytometry. As shown in Figure 2B -D, the percentages of CD66B + neutrophils and CD177 + CD66B + neutrophils were found to be higher in colorectal tumours than those in paired distant normal colon tissues and HC. These data suggest that CD177 + neutrophils may be involved in the process of colorectal carcinogenesis.
Correlations between CD177 expression and clinicopathological characteristics
To further determine whether CD177 expression was associated with clinical progression of CRC, 378 paraffin-embedded CRC specimens were collected and used for immunohistochemistry analysis. According to the median density (8 cells/HPF) of CD177 + neutrophils (22) , 378 CRC patients were classified into high-density group (>8 cells/HPF) and low-density group (≤8 cells/HPF) (22) . The representative immunostaining of CD177 + neutrophils was shown in Supplementary Figure 1 + neutrophils and survival outcomes, we employed the Kaplan-Meier survival curve analysis and found that patients with high density of CD177 + neutrophils had better 5-year OS than those with low density (80.4% versus 69.3%, P = 0.007; Figure 2E ). Consistently, 5-year DFS was significantly longer in high-density group (81.7% versus 71.6%, P = 0.010; Figure 2F ) compared with controls. These data indicate that high density of CD177 + neutrophil infiltration predicts favorable survival outcomes in patients with CRC.
To assess whether CD177 + neutrophils could be used as an indicator for OS and DFS, univariate analysis and multivariate analysis were employed. As shown in Tables 1 and 2 , univariate analysis revealed that the density of CD177 + neutrophils (HR = 0.578, 95% CI 0.386-0.865, P = 0.008; HR = 0.559, 95% CI 0.356-0.877, P = 0.011), TNM stage (HR = 3.157, 95% CI 2.047-4.870, P = 0.000; HR = 1.752, 95% CI 1.122-2.736, P = 0.014), and tumour differentiation (HR = 1.947, 95% CI 1.040-3.645, P = 0.037; HR = 2.640, 95% CI 1.396-4.991, P = 0.003) were remarkable factors affecting OS and DFS of CRC patients. However, age, gender and tumour site did not affect OS and DFS. In addition, multivariate Cox regression analyses were conducted. After adjustment for all potential factors that may have a clinical impact on OS and DFS, the density of CD177 + neutrophils (HR = 0.582, 95% CI 0.388-0.872, P = 0.009) along with TNM stage (HR = 3.032, 95% CI 1.962-4.688, P = 0.000) was an independent indicator for predicting the OS in CRC (Table 1) , whereas the density of CD177 + neutrophils (HR = 0.509, 95% CI 0.323-0.802, P = 0.004), TNM stage (HR = 1.784, 95% CI 1.138-2.799, P = 0.012) and tumour differentiation (HR = 2.563, 95% CI 1.347-4.877, P = 0.004) were significantly associated with DFS of CRC patients (Table 2) . Collectively, these data suggest that the density of CD177 + neutrophils predicts good prognosis in CRC independently.
Depletion of CD177 aggravates CAC in mice
We next established an experimental model of CAC in mice induced by administration of AOM and DSS as described previously (25) , and examined CD177 mRNA expression in experimental CAC. We found that the levels of CD177 mRNA in colon tumours were markedly higher than those in normal colon mucosa ( Figure 3A) , consistent with the results in patients with Figure 2A ). To test our hypothesis that CD177 + neutrophils could protect the colon from tumourigenesis, we introduced CD177 -/-mice and established mouse model of CAC. WT and CD177 -/-mice were injected intraperitoneally with AOM, followed by three cycles of 1.5% DSS in drinking water, as described previously (25) . We found that CD177 -/-mice presented more weight loss compared with WT mice after exposure to AOM/DSS ( Figure 3B ). All mice were sacrificed on day 81, and we found that the length of the colon was much shorter in CD177 -/-mice than that in WT mice ( Figure 3C and D) . CD177 -/-mice developed multiple and large colon tumours. The number and size of tumours in CD177 -/-mice were markedly increased compared with WT controls (Figure 3E-H) . H&E staining revealed more severe tumourigenesis in CD177 -/-mice than in WT controls ( Figure 3I ). We also found that in tumours from CD177 -/-mouse, glandular tissue structure was disordered or even disappeared, and that there were more glands fusion, glands back-to-back, tubular or sieving adenocarcinoma structure compared with WT mice ( Figure 3I ). Structural heteromorphism was more obvious, and more tumour cells were infiltrated in submucosa layer of CD177 -/-mice compared with WT controls, indicating severe tumourigenesis in CD177 -/-mice. Taken together, these data indicate that CD177 -/-mice are more susceptible to colon cancer and that CD177 + neutrophils are able to suppress epithelial cell tumourigenesis in CRC.
CRC (
CD177 deficiency promotes the proliferation of colonic epithelial cells, inflammatory response, tissue remodelling and decreases neutrophil migration
To further study how CD177 regulates colon tumourigenesis, we performed immunostaining for Ki67 and proliferating cell nuclear antigen in tumour tissues to examine whether CD177 could modulate the proliferation of colonic epithelial cells, and observed that the expression of Ki67 and proliferating cell nuclear antigen was significantly increased in tumour tissues from CD177 -/-mice compared with that from WT mice ( Figure 4A-C) . However, there was no significant difference in the expression of Ki67 and proliferating cell nuclear antigen in colon mucosa between WT and CD177 -/-mice before AOM/ DSS treatment ( Figure 4A-C) . We examined the expression of inflammatory cytokines in tumour tissues from WT and CD177 -/-mice, and found that the expression of interleukin-1β (IL-1β) and IL-6 was increased, whereas the expression of interferon-γ and TGF-β was decreased in tumour tissues from CD177 -/-mice compared with WT controls. Furthermore, we also observed that the expression of hypoxia inducible factor (HIF)-1α and matrix metalloproteinase-10, which are reported to be involved in the process of tissue remodelling in tumourigenesis, was increased in tumour tissues from CD177 -/-mice compared with controls ( Figure 4D-I) .
CD177 has been shown to mediate neutrophil-endothelial cell interaction and promote neutrophil transmigration (17) . To further explore the role of CD177 in regulating the development of CAC, we then investigated whether CD177 mediates neutrophil migration, and found that the frequency of CD11b Overall, these data indicate that CD177 deficiency reduces the capacity of neutrophil migration to colon. To further test our hypothesis that CD177 participates in neutrophil migration, chemotaxis towards formyl-methionylleucyl-phenylalanine (fMLP) was examined in vitro in Transwells. Neutrophils were isolated from the bone marrow of WT and CD177 -/-mice after AOM/DSS treatment, and placed in the upper chamber under stimulation with fMLP. CD177 -/-neutrophils were observed to have markedly decreased capacity of migration in response to fMLP in a dose-dependent manner compared with WT controls ( Figure 4J ). Taken together, these data indicate that CD177 deficiency decreases neutrophil migration.
Discussion
CRC is still one of the most dreadful malignant diseases with high mortality, owing to tumour metastasis and recurrence (2, 26) . Studies have performed a quantitative proteomic analysis to discover CRC biomarker candidates, which offer guidance to evaluate the risk progression indication and OS prognosis (27) . In our current study, we found that the expression of CD177, especially expressed in neutrophils, was highly increased in tumour tissues from patients with CRC and UC-associated cancer, and that high density of CD177 + neutrophils in CRC was positively correlated with favorable survival of CRC patients. Moreover, knockdown of CD177 was demonstrated to promote the tumourigenesis of AOM/DSS-induced colon cancer in mice.
It is well established that chronic inflammation is closely associated with the tumourigenesis (1,28) . The role of inflammmatory network has been well studied previously, and, importantly, patients with UC have an increased risk in developing CRC (29) . Previous study has reported upregulated genes (e.g. toll-like receptors, IL-8 and triggering receptor expressed on myeloid cells 1) are associated with intestinal mucosal inflammation (30) . In CRC, tumour formation precedes inflammation occurrence in intestinal mucosa (2) . After tumour formation, immune cells are recruited and infiltrated in tumour tissues, and then produce reactive oxygen and nitrogen intermediates, which induce DNA damage and mutation, and further tumour development (31, 32) . However, chronic inflammation in CAC occurs prior to tumour development and induces mutagenesis through oxidative damage to DNA (33) . In CRC and CAC, several cytokines (e.g. TNF-α, IL-6, IL-1β and IL-10), produced by infiltrated immune cells in tumour milieu, can serve as tumour growth factors by promoting angiogenesis and suppressing tumour elimination, and modulators in the activation of inflammatory signaling pathway and recruitment of immune cells (8, 34) . Neutrophils as the first-line host defense against invading pathogens are one of the most abundant population of infiltrating immune cells (35) . Tumour-activated neutrophils can be detected in most of intratumoural stroma, including hepatocellular carcinoma, lung cancer, and CRC (36) (37) (38) . Moreover, the infiltration of neutrophils in colorectal adenomas is found to be increased compared with that in adjacent normal mucosa (39) . In our study, we detected the expression of CD177 in patients with CRC and observed that the expression of CD177 mRNA was significantly enhanced in colorectal tumour compared with that in paired distant normal colon tissues and healthy mucosa. The percentage of CD177 + neutrophils was found to be increased in intratumoural stroma of CRC. Several lines of evidence have demonstrated that chronic inflammation is a major driving cause for the initiation and progression of many cancers (40) . Previous data have reported that patients with UC account for an increased risk in developing CRC (41, 42) . Therefore, we questioned whether CD177 participated in the initiation and progression of CAC, and collected colorectal sections from patients with UC and UC-associated cancer. We observed that percentage of CD177 + neutrophils was significantly increased in patients with UC and UC-associated cancer. Therefore, these data indicate that CD177 + neutrophils participate in the modulation of inflammatory response in CRC and CAC.
Neutrophils constitute a critical portion of inflammatory cells infiltrated in tumours, and have plastic functions, which are context dependent (43) . It is reported that neutrophils exert antitumour activities after blockade of TGF-β (N1 phenotype), including directly inducing lysis and apoptosis of tumour cells, higher production of reactive oxygen species, reactive nitrogen species or proteases, which have cytotoxic effects on cancer cells, enhanced levels of immunoactivating cytokines and chemokines, and antibody-dependent cell-mediated cytotoxicity (44, 45) . Moreover, in the presence of arginase 1, neutrophils promote the activation of cytotoxic T lymphocytes (e.g. CD8 + T cells), which are endowed with a higher capacity to kill tumour cells and further suppress tumour progression (14, 46) . interferon-β has been reported to be an important factor for the maintenance of N1 polarization (47, 48) . On the contrary, in the presence of TGF-β and absence of interferon-β, neutrophils are demonstrated to be a pro-tumour phenotype (N2 phenotype), which facilitates tumour growth and enhances tumour metastasis through degrading extracellular matrix and releasing a wide spectrum of factors (e.g. vascular endothelial growth factor and matrix metalloproteinase-9) enhancing proliferation of malignant cells and augmenting tumour angiogenesis (48) . Therefore, the role of neutrophils in carcinoma is controversial. However, in our current study, we observed that depletion of CD177, which is specially expressed in neutrophils, significantly aggravated AOM/DSS-induced tumourigenesis, characterised by larger and more tumour formation. Previous studies have found that depletion of neutrophils markedly reduces the number and size of tumours in CAC model, indicating a crucial role for neutrophils in the initiation and progression of CAC (49) (50) (51) . We observed enhanced inflammation and activation of tumourassociated signals in tumours from CD177 -/-mice. CD177 deficiency could promote the proliferation of colonic epithelial cells, inflammatory response and tissueremodelling, which may induce enlarged tumour size and aggravated tumour formation in CD177 -/-mice. However, the underlying mechanisms need further studies.
Evidence has demonstrated that infiltration of neutrophils in tumours is a key feature of inflammation-associated cancer (52) . We found that the frequencies of CD177 + neutrophils were increased in UC, UC-associated cancer and CRC. Moreover, previous studies have shown that decrease of neutrophil chemotaxis to some chemotactic mediators is correlated with disease aggravation and organ damage (53) . Massive infiltration of neutrophil in gut mucosa is thought to be involved in the pathogenesis of inflammatory bowel disease (54) , and continuous recruitment of neutrophils into tumours is reported to participate in the process of tumour growth and metastasis (15, 55) . Here, we observed that percentage of neutrophils was increased in the bone marrow and spleen, but decreased in colon tumours in CD177
-/-mice after AOM/DSS treatment, and that the migratory capacity of neutrophils from WT mice was enhanced compared with CD177 -/-control. Deficiency of CD177 greatly impaired neutrophil migration from the bone morrow into colonic tumours, leading to decreased accumulation of neutrophils in colon tumours. Furthermore, through coculturing with intestinal epithelial cells, we found that CD177 + neutrophils produced high levels of ROS (data not shown), which could eliminate the cancerous cells directly (56) . Therefore, it is envisaged that CD177 + neutrophils may exert anti-inflammatory effects through its cytotoxic functions against CRC-targeted microbiota. In addition, CD177 + neutrophils may also exert immunoregulatory effects on other immune cells, including macrophages, T and B lymphocytes (37) . Further studies (e.g. neutrophil and microbiota interaction) may be warranted to focus on the mechanisms by which CD177 + neutrophils mediate colitis-associated tumourigenesis (57) . Altogether, our data indicate that CD177 + neutrophils function as an activated population of neutrophils and play a critical role in the tumourigenesis of CRC.
Previous study has demonstrated that several genes including CD177 act as good candidate genes that correlate with the development of CRC (58, 59) . CD177 is found to be upregulated in gastric cancer and predicts a favorable prognosis in these patients. Multivariate analysis has also revealed that high expression of CD177 in gastric cancer is an independent prognostic factor for OS (18) . In our current study, CD177 expression was significantly enhanced in patients with CRC and UC-associated cancer. Correlation analysis identified the association between the density of CD177 + neutrophils and clinicopathologic features, indicating that high density of CD177 + neutrophils in CRC is highly associated with the survival of patients with CRC. Further analysis further confirmed that CRC patients with high density of CD177 + neutrophils had longer OS and DFS compared with those with low density of CD177 + neutrophils. In addition, we observed that high density of CD177 + neutrophils was an independent factor in predicting OS and DFS along with TNM stage, which was consistent with the results in gastric cancer (18) . Thus, the current data indicate that high density of CD177 + neutrophils predicts good prognosis in CRC. To the best our knowledge, it is the first report showing prognostic value of CD177 + neutrophils in patients with CRC.
In summary, our study demonstrates that CD177 + neutrophils, as a functionally population of neutrophils, suppress epithelial cell tumourigenesis. High density of CD177 + neutrophils is highly associated with the survival of CRC patients and appears to be an independent factor in predicting good prognosis in patients with CRC. Therefore, CD177 or CD177 + neutrophils may serve as a novel therapeutic target in the treatment and prognosis of CAC and CRC.
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